Global Pemetrexed Market Growth (Status and Outlook) 2025-2031

December 2025 | 76 pages | ID: G9CBB47D1B3EN
LP Information

Abstracts

According to this study, the global Pemetrexed market size will reach US$ 1854 million by 2031.

Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer.

United States market for Pemetrexed is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Pemetrexed is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Pemetrexed is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Pemetrexed players cover Eli Lilly, Abbott Laboratories, Cadila Healthcare, Eagle Pharmaceuticals, Stada Arzneimittel, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Pemetrexed Industry Forecast” looks at past sales and reviews total world Pemetrexed sales in 2024, providing a comprehensive analysis by region and market sector of projected Pemetrexed sales for 2025 through 2031. With Pemetrexed sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pemetrexed industry.

This Insight Report provides a comprehensive analysis of the global Pemetrexed landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pemetrexed portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pemetrexed market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pemetrexed and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pemetrexed.

This report presents a comprehensive overview, market shares, and growth opportunities of Pemetrexed market by product type, application, key players and key regions and countries.

Segmentation by Type:

• 100mg
• 500mg

Segmentation by Application:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Eli Lilly
• Abbott Laboratories
• Cadila Healthcare
• Eagle Pharmaceuticals
• Stada Arzneimittel

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pemetrexed Market Size (2020-2031)
  2.1.2 Pemetrexed Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Pemetrexed by Country/Region (2020, 2024 & 2031)
2.2 Pemetrexed Segment by Type
  2.2.1 100mg
  2.2.2 500mg
2.3 Pemetrexed Market Size by Type
  2.3.1 Pemetrexed Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Pemetrexed Market Size Market Share by Type (2020-2025)
2.4 Pemetrexed Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 Pemetrexed Market Size by Application
  2.5.1 Pemetrexed Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Pemetrexed Market Size Market Share by Application (2020-2025)

3 PEMETREXED MARKET SIZE BY PLAYER

3.1 Pemetrexed Market Size Market Share by Player
  3.1.1 Global Pemetrexed Revenue by Player (2020-2025)
  3.1.2 Global Pemetrexed Revenue Market Share by Player (2020-2025)
3.2 Global Pemetrexed Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PEMETREXED BY REGION

4.1 Pemetrexed Market Size by Region (2020-2025)
4.2 Global Pemetrexed Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pemetrexed Market Size Growth (2020-2025)
4.4 APAC Pemetrexed Market Size Growth (2020-2025)
4.5 Europe Pemetrexed Market Size Growth (2020-2025)
4.6 Middle East & Africa Pemetrexed Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Pemetrexed Market Size by Country (2020-2025)
5.2 Americas Pemetrexed Market Size by Type (2020-2025)
5.3 Americas Pemetrexed Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pemetrexed Market Size by Region (2020-2025)
6.2 APAC Pemetrexed Market Size by Type (2020-2025)
6.3 APAC Pemetrexed Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Pemetrexed Market Size by Country (2020-2025)
7.2 Europe Pemetrexed Market Size by Type (2020-2025)
7.3 Europe Pemetrexed Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pemetrexed by Region (2020-2025)
8.2 Middle East & Africa Pemetrexed Market Size by Type (2020-2025)
8.3 Middle East & Africa Pemetrexed Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PEMETREXED MARKET FORECAST

10.1 Global Pemetrexed Forecast by Region (2026-2031)
  10.1.1 Global Pemetrexed Forecast by Region (2026-2031)
  10.1.2 Americas Pemetrexed Forecast
  10.1.3 APAC Pemetrexed Forecast
  10.1.4 Europe Pemetrexed Forecast
  10.1.5 Middle East & Africa Pemetrexed Forecast
10.2 Americas Pemetrexed Forecast by Country (2026-2031)
  10.2.1 United States Market Pemetrexed Forecast
  10.2.2 Canada Market Pemetrexed Forecast
  10.2.3 Mexico Market Pemetrexed Forecast
  10.2.4 Brazil Market Pemetrexed Forecast
10.3 APAC Pemetrexed Forecast by Region (2026-2031)
  10.3.1 China Pemetrexed Market Forecast
  10.3.2 Japan Market Pemetrexed Forecast
  10.3.3 Korea Market Pemetrexed Forecast
  10.3.4 Southeast Asia Market Pemetrexed Forecast
  10.3.5 India Market Pemetrexed Forecast
  10.3.6 Australia Market Pemetrexed Forecast
10.4 Europe Pemetrexed Forecast by Country (2026-2031)
  10.4.1 Germany Market Pemetrexed Forecast
  10.4.2 France Market Pemetrexed Forecast
  10.4.3 UK Market Pemetrexed Forecast
  10.4.4 Italy Market Pemetrexed Forecast
  10.4.5 Russia Market Pemetrexed Forecast
10.5 Middle East & Africa Pemetrexed Forecast by Region (2026-2031)
  10.5.1 Egypt Market Pemetrexed Forecast
  10.5.2 South Africa Market Pemetrexed Forecast
  10.5.3 Israel Market Pemetrexed Forecast
  10.5.4 Turkey Market Pemetrexed Forecast
10.6 Global Pemetrexed Forecast by Type (2026-2031)
10.7 Global Pemetrexed Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Pemetrexed Forecast

11 KEY PLAYERS ANALYSIS

11.1 Eli Lilly
  11.1.1 Eli Lilly Company Information
  11.1.2 Eli Lilly Pemetrexed Product Offered
  11.1.3 Eli Lilly Pemetrexed Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Eli Lilly Main Business Overview
  11.1.5 Eli Lilly Latest Developments
11.2 Abbott Laboratories
  11.2.1 Abbott Laboratories Company Information
  11.2.2 Abbott Laboratories Pemetrexed Product Offered
  11.2.3 Abbott Laboratories Pemetrexed Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Abbott Laboratories Main Business Overview
  11.2.5 Abbott Laboratories Latest Developments
11.3 Cadila Healthcare
  11.3.1 Cadila Healthcare Company Information
  11.3.2 Cadila Healthcare Pemetrexed Product Offered
  11.3.3 Cadila Healthcare Pemetrexed Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Cadila Healthcare Main Business Overview
  11.3.5 Cadila Healthcare Latest Developments
11.4 Eagle Pharmaceuticals
  11.4.1 Eagle Pharmaceuticals Company Information
  11.4.2 Eagle Pharmaceuticals Pemetrexed Product Offered
  11.4.3 Eagle Pharmaceuticals Pemetrexed Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Eagle Pharmaceuticals Main Business Overview
  11.4.5 Eagle Pharmaceuticals Latest Developments
11.5 Stada Arzneimittel
  11.5.1 Stada Arzneimittel Company Information
  11.5.2 Stada Arzneimittel Pemetrexed Product Offered
  11.5.3 Stada Arzneimittel Pemetrexed Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Stada Arzneimittel Main Business Overview
  11.5.5 Stada Arzneimittel Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Pemetrexed Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Pemetrexed Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 100mg
Table 4. Major Players of 500mg
Table 5. Pemetrexed Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Pemetrexed Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Pemetrexed Market Size Market Share by Type (2020-2025)
Table 8. Pemetrexed Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Pemetrexed Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Pemetrexed Market Size Market Share by Application (2020-2025)
Table 11. Global Pemetrexed Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Pemetrexed Revenue Market Share by Player (2020-2025)
Table 13. Pemetrexed Key Players Head office and Products Offered
Table 14. Pemetrexed Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Pemetrexed Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Pemetrexed Market Size Market Share by Region (2020-2025)
Table 19. Global Pemetrexed Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Pemetrexed Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Pemetrexed Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Pemetrexed Market Size Market Share by Country (2020-2025)
Table 23. Americas Pemetrexed Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Pemetrexed Market Size Market Share by Type (2020-2025)
Table 25. Americas Pemetrexed Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Pemetrexed Market Size Market Share by Application (2020-2025)
Table 27. APAC Pemetrexed Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Pemetrexed Market Size Market Share by Region (2020-2025)
Table 29. APAC Pemetrexed Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Pemetrexed Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Pemetrexed Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Pemetrexed Market Size Market Share by Country (2020-2025)
Table 33. Europe Pemetrexed Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Pemetrexed Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Pemetrexed Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Pemetrexed Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Pemetrexed Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Pemetrexed
Table 39. Key Market Challenges & Risks of Pemetrexed
Table 40. Key Industry Trends of Pemetrexed
Table 41. Global Pemetrexed Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Pemetrexed Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Pemetrexed Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Pemetrexed Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Eli Lilly Details, Company Type, Pemetrexed Area Served and Its Competitors
Table 46. Eli Lilly Pemetrexed Product Offered
Table 47. Eli Lilly Pemetrexed Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Eli Lilly Main Business
Table 49. Eli Lilly Latest Developments
Table 50. Abbott Laboratories Details, Company Type, Pemetrexed Area Served and Its Competitors
Table 51. Abbott Laboratories Pemetrexed Product Offered
Table 52. Abbott Laboratories Pemetrexed Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Abbott Laboratories Main Business
Table 54. Abbott Laboratories Latest Developments
Table 55. Cadila Healthcare Details, Company Type, Pemetrexed Area Served and Its Competitors
Table 56. Cadila Healthcare Pemetrexed Product Offered
Table 57. Cadila Healthcare Pemetrexed Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Cadila Healthcare Main Business
Table 59. Cadila Healthcare Latest Developments
Table 60. Eagle Pharmaceuticals Details, Company Type, Pemetrexed Area Served and Its Competitors
Table 61. Eagle Pharmaceuticals Pemetrexed Product Offered
Table 62. Eagle Pharmaceuticals Pemetrexed Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Eagle Pharmaceuticals Main Business
Table 64. Eagle Pharmaceuticals Latest Developments
Table 65. Stada Arzneimittel Details, Company Type, Pemetrexed Area Served and Its Competitors
Table 66. Stada Arzneimittel Pemetrexed Product Offered
Table 67. Stada Arzneimittel Pemetrexed Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Stada Arzneimittel Main Business
Table 69. Stada Arzneimittel Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Pemetrexed Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pemetrexed Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Pemetrexed Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Pemetrexed Sales Market Share by Country/Region (2024)
Figure 8. Pemetrexed Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Pemetrexed Market Size Market Share by Type in 2024
Figure 10. Pemetrexed in Hospital Pharmacies
Figure 11. Global Pemetrexed Market: Hospital Pharmacies (2020-2025) & ($ millions)
Figure 12. Pemetrexed in Retail Pharmacies
Figure 13. Global Pemetrexed Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 14. Pemetrexed in Online Pharmacies
Figure 15. Global Pemetrexed Market: Online Pharmacies (2020-2025) & ($ millions)
Figure 16. Global Pemetrexed Market Size Market Share by Application in 2024
Figure 17. Global Pemetrexed Revenue Market Share by Player in 2024
Figure 18. Global Pemetrexed Market Size Market Share by Region (2020-2025)
Figure 19. Americas Pemetrexed Market Size 2020-2025 ($ millions)
Figure 20. APAC Pemetrexed Market Size 2020-2025 ($ millions)
Figure 21. Europe Pemetrexed Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Pemetrexed Market Size 2020-2025 ($ millions)
Figure 23. Americas Pemetrexed Value Market Share by Country in 2024
Figure 24. United States Pemetrexed Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Pemetrexed Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Pemetrexed Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Pemetrexed Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Pemetrexed Market Size Market Share by Region in 2024
Figure 29. APAC Pemetrexed Market Size Market Share by Type (2020-2025)
Figure 30. APAC Pemetrexed Market Size Market Share by Application (2020-2025)
Figure 31. China Pemetrexed Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Pemetrexed Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Pemetrexed Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Pemetrexed Market Size Growth 2020-2025 ($ millions)
Figure 35. India Pemetrexed Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Pemetrexed Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Pemetrexed Market Size Market Share by Country in 2024
Figure 38. Europe Pemetrexed Market Size Market Share by Type (2020-2025)
Figure 39. Europe Pemetrexed Market Size Market Share by Application (2020-2025)
Figure 40. Germany Pemetrexed Market Size Growth 2020-2025 ($ millions)
Figure 41. France Pemetrexed Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Pemetrexed Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Pemetrexed Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Pemetrexed Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Pemetrexed Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Pemetrexed Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Pemetrexed Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Pemetrexed Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Pemetrexed Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Pemetrexed Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Pemetrexed Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Pemetrexed Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Pemetrexed Market Size 2026-2031 ($ millions)
Figure 54. APAC Pemetrexed Market Size 2026-2031 ($ millions)
Figure 55. Europe Pemetrexed Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Pemetrexed Market Size 2026-2031 ($ millions)
Figure 57. United States Pemetrexed Market Size 2026-2031 ($ millions)
Figure 58. Canada Pemetrexed Market Size 2026-2031 ($ millions)
Figure 59. Mexico Pemetrexed Market Size 2026-2031 ($ millions)
Figure 60. Brazil Pemetrexed Market Size 2026-2031 ($ millions)
Figure 61. China Pemetrexed Market Size 2026-2031 ($ millions)
Figure 62. Japan Pemetrexed Market Size 2026-2031 ($ millions)
Figure 63. Korea Pemetrexed Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Pemetrexed Market Size 2026-2031 ($ millions)
Figure 65. India Pemetrexed Market Size 2026-2031 ($ millions)
Figure 66. Australia Pemetrexed Market Size 2026-2031 ($ millions)
Figure 67. Germany Pemetrexed Market Size 2026-2031 ($ millions)
Figure 68. France Pemetrexed Market Size 2026-2031 ($ millions)
Figure 69. UK Pemetrexed Market Size 2026-2031 ($ millions)
Figure 70. Italy Pemetrexed Market Size 2026-2031 ($ millions)
Figure 71. Russia Pemetrexed Market Size 2026-2031 ($ millions)
Figure 72. Egypt Pemetrexed Market Size 2026-2031 ($ millions)
Figure 73. South Africa Pemetrexed Market Size 2026-2031 ($ millions)
Figure 74. Israel Pemetrexed Market Size 2026-2031 ($ millions)
Figure 75. Turkey Pemetrexed Market Size 2026-2031 ($ millions)
Figure 76. Global Pemetrexed Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Pemetrexed Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Pemetrexed Market Size 2026-2031 ($ millions)